Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 21.24M 19.82M 17.97M 33.73M 2.25B 33.94M 238M 92.89M 1.17B 88.7M 86.78M 3.75B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 37.93M 35.4M 32.08M 60.23M 4.01B 60.6M 425M 166M 2.08B 158M 155M 6.7B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
17-08-04 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
17-05-15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
17-02-13 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
16-11-13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
16-10-04 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16-05-16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
16-02-08 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
16-02-01 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
15-12-10 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
15-12-04 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
15-12-01 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
15-11-13 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
15-10-12 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 week+90.91%
Current month+90.91%
1 month-2.33%
3 months+20.00%
Current year+27.27%
1 month 0
Extreme 0.0022
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+90.91%-46.15%+250.00% 877K
-1.58%+1.08%-34.84%-54.83% 1.72B
-2.18%-2.11% - - 1.55B
-1.22%+14.57%-41.47%+25.39% 1.16B
+3.23%+0.54%-35.99%+141.66% 1.12B
+0.76%+5.75%+45.72%+42.93% 991M
-4.88%-11.73%+157.66%+708.77% 831M
+2.62%-2.90%+2.66%+167.04% 715M
-4.99%-6.43%-0.99%+39.37% 701M
+0.11%+3.02%+43.00%-33.93% 534M
Average -0.81%+0.63%+9.96%+142.93% 932.41M
Weighted average by Cap. -0.94%+1.24%+6.71%+109.92%

Financials

2015 2016
Net sales 25.48M 22.91M 21.38M 19.38M 36.38M 2.42B 36.61M 257M 100M 1.26B 95.67M 93.59M 4.05B 32.33M 29.07M 27.13M 24.58M 46.16M 3.08B 46.44M 326M 127M 1.6B 121M 119M 5.14B
Net income 5.49M 4.94M 4.61M 4.18M 7.84M 523M 7.89M 55.33M 21.6M 271M 20.63M 20.18M 873M 2.06M 1.85M 1.73M 1.57M 2.94M 196M 2.96M 20.76M 8.1M 102M 7.74M 7.57M 327M
Net Debt 24.8M 22.3M 20.81M 18.86M 35.41M 2.36B 35.63M 250M 97.53M 1.23B 93.13M 91.11M 3.94B 18.56M 16.69M 15.57M 14.11M 26.5M 1.77B 26.66M 187M 72.97M 917M 69.68M 68.17M 2.95B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. AOXG Stock